Moderate Emetic Risk Intravenous Antineoplastic Agent
activeURL
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.5.243Copied!
Version20220910Copied!
PublisherAmerican Society of Clinical Oncology StewardDate2022-09-10T01:02:30-04:00Purpose(Clinical Focus: The purpose of this value set is to represent concepts of moderate emetic risk intravenous antineoplastic agent.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent a moderate emetic risk intravenous antineoplastic medication; generic; prescribable; injectable.),(Exclusion Criteria: Excludes concepts that represent non-prescribable branded drugs, components or ingredients.)
Expansion
| Code | Display | System |
|---|---|---|
| 309650 | http://www.nlm.nih.gov/research/umls/rxnorm | |
| 2002002 | http://www.nlm.nih.gov/research/umls/rxnorm | |
| 1191138 | http://www.nlm.nih.gov/research/umls/rxnorm | |
| 1790103 | http://www.nlm.nih.gov/research/umls/rxnorm | |
| 1790099 | http://www.nlm.nih.gov/research/umls/rxnorm | |
| 1790095 | http://www.nlm.nih.gov/research/umls/rxnorm | |
| 1790097 | http://www.nlm.nih.gov/research/umls/rxnorm | |
| 1790100 | http://www.nlm.nih.gov/research/umls/rxnorm | |
| 1872062 | http://www.nlm.nih.gov/research/umls/rxnorm | |
| 1732182 | http://www.nlm.nih.gov/research/umls/rxnorm | |
| 1732186 | http://www.nlm.nih.gov/research/umls/rxnorm | |
| 1791498 | http://www.nlm.nih.gov/research/umls/rxnorm | |
| 1791493 | http://www.nlm.nih.gov/research/umls/rxnorm | |
| 1791500 | http://www.nlm.nih.gov/research/umls/rxnorm | |
| 1726097 | http://www.nlm.nih.gov/research/umls/rxnorm | |
| 1726319 | http://www.nlm.nih.gov/research/umls/rxnorm | |
| 829926 | http://www.nlm.nih.gov/research/umls/rxnorm | |
| 1594658 | http://www.nlm.nih.gov/research/umls/rxnorm | |
| 1736784 | http://www.nlm.nih.gov/research/umls/rxnorm | |
| 1942743 | http://www.nlm.nih.gov/research/umls/rxnorm |
valueSethttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.332
valueSethttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.168
valueSethttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.200
valueSethttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.153
valueSethttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.223
{
"compose" : {
"exclude" : [ ],
"include" : [ {
"valueSet" : [ "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.332" ]
}, {
"valueSet" : [ "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.168" ]
}, {
"valueSet" : [ "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.200" ]
}, {
"valueSet" : [ "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.153" ]
}, {
"valueSet" : [ "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.223" ]
} ]
},
"date" : "2022-09-10T01:02:30-04:00",
"meta" : {
"versionId" : "7",
"lastUpdated" : "2023-12-21T17:43:03.000-05:00",
"profile" : [ "http://hl7.org/fhir/StructureDefinition/shareablevalueset", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm" ]
},
"publisher" : "American Society of Clinical Oncology Steward",
"jurisdiction" : [ {
"coding" : [ {
"system" : "urn:iso:std:iso:3166",
"code" : "US"
} ]
} ],
"purpose" : "(Clinical Focus: The purpose of this value set is to represent concepts of moderate emetic risk intravenous antineoplastic agent.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent a moderate emetic risk intravenous antineoplastic medication; generic; prescribable; injectable.),(Exclusion Criteria: Excludes concepts that represent non-prescribable branded drugs, components or ingredients.)",
"name" : "ModerateEmeticRiskIntravenousAntineoplasticAgent",
"experimental" : false,
"resourceType" : "ValueSet",
"expansion" : {
"contains" : [ {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "1191138",
"display" : "doxorubicin hydrochloride 2 MG/ML Injectable Solution",
"version" : "04012024"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "1594658",
"display" : "1.2 ML alemtuzumab 10 MG/ML Injection",
"version" : "04012024"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "1660004",
"display" : "thiotepa 100 MG Injection",
"version" : "04012024"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "1660009",
"display" : "thiotepa 15 MG Injection",
"version" : "04012024"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "1718589",
"display" : "trabectedin 1 MG Injection",
"version" : "04012024"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "1719772",
"display" : "10 ML irinotecan hydrochloride liposome 4.3 MG/ML Injection",
"version" : "04012024"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "1726097",
"display" : "bendamustine hydrochloride 25 MG/ML Injectable Solution",
"version" : "04012024"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "1726319",
"display" : "2 ML irinotecan hydrochloride 20 MG/ML Injection",
"version" : "04012024"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "1726324",
"display" : "5 ML irinotecan hydrochloride 20 MG/ML Injection",
"version" : "04012024"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "1726333",
"display" : "15 ML irinotecan hydrochloride 20 MG/ML Injection",
"version" : "04012024"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "1726492",
"display" : "25 ML irinotecan hydrochloride 20 MG/ML Injection",
"version" : "04012024"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "1732182",
"display" : "25 ML epirubicin hydrochloride 2 MG/ML Injection",
"version" : "04012024"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "1732186",
"display" : "100 ML epirubicin hydrochloride 2 MG/ML Injection",
"version" : "04012024"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "1736776",
"display" : "10 ML oxaliplatin 5 MG/ML Injection",
"version" : "04012024"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "1736781",
"display" : "20 ML oxaliplatin 5 MG/ML Injection",
"version" : "04012024"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "1736784",
"display" : "oxaliplatin 50 MG Injection",
"version" : "04012024"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "1736786",
"display" : "oxaliplatin 100 MG Injection",
"version" : "04012024"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "1790095",
"display" : "doxorubicin hydrochloride 50 MG Injection",
"version" : "04012024"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "1790097",
"display" : "5 ML doxorubicin hydrochloride 2 MG/ML Injection",
"version" : "04012024"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "1790099",
"display" : "10 ML doxorubicin hydrochloride 2 MG/ML Injection",
"version" : "04012024"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "1790100",
"display" : "25 ML doxorubicin hydrochloride 2 MG/ML Injection",
"version" : "04012024"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "1790103",
"display" : "doxorubicin hydrochloride 10 MG Injection",
"version" : "04012024"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "1791493",
"display" : "20 ML idarubicin hydrochloride 1 MG/ML Injection",
"version" : "04012024"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "1791498",
"display" : "10 ML idarubicin hydrochloride 1 MG/ML Injection",
"version" : "04012024"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "1791500",
"display" : "5 ML idarubicin hydrochloride 1 MG/ML Injection",
"version" : "04012024"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "1791588",
"display" : "ifosfamide 3000 MG Injection",
"version" : "04012024"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "1791593",
"display" : "ifosfamide 1000 MG Injection",
"version" : "04012024"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "1791597",
"display" : "60 ML ifosfamide 50 MG/ML Injection",
"version" : "04012024"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "1791599",
"display" : "20 ML ifosfamide 50 MG/ML Injection",
"version" : "04012024"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "1797528",
"display" : "40 ML oxaliplatin 5 MG/ML Injection",
"version" : "04012024"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "1805001",
"display" : "bendamustine hydrochloride 100 MG Injection",
"version" : "04012024"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "1805007",
"display" : "bendamustine hydrochloride 25 MG Injection",
"version" : "04012024"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "1872062",
"display" : "doxorubicin hydrochloride 20 MG Injection",
"version" : "04012024"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "1942743",
"display" : "cytarabine liposome 100 MG / daunorubicin liposomal 44 MG Injection",
"version" : "04012024"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "1992545",
"display" : "6 ML arsenic trioxide 2 MG/ML Injection",
"version" : "04012024"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "2002002",
"display" : "10 ML daunorubicin 5 MG/ML Injection",
"version" : "04012024"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "2267576",
"display" : "fam-trastuzumab deruxtecan-nxki 100 MG Injection",
"version" : "04012024"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "2289413",
"display" : "5.5 ML romidepsin 5 MG/ML Injection",
"version" : "04012024"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "249364",
"display" : "20 ML cytarabine 100 MG/ML Injection",
"version" : "04012024"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "253113",
"display" : "10 ML busulfan 6 MG/ML Injection",
"version" : "04012024"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "309650",
"display" : "4 ML daunorubicin 5 MG/ML Injection",
"version" : "04012024"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "485246",
"display" : "azacitidine 100 MG Injection",
"version" : "04012024"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "486419",
"display" : "20 ML clofarabine 1 MG/ML Injection",
"version" : "04012024"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "597195",
"display" : "carboplatin 10 MG/ML Injectable Solution",
"version" : "04012024"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "828265",
"display" : "1 ML alemtuzumab 30 MG/ML Injection",
"version" : "04012024"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "829926",
"display" : "10 ML arsenic trioxide 1 MG/ML Injection",
"version" : "04012024"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "835945",
"display" : "temozolomide 100 MG Injection",
"version" : "04012024"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "877513",
"display" : "romidepsin 10 MG Injection",
"version" : "04012024"
} ],
"total" : 48,
"identifier" : "urn:uuid:11e1cc53-2f15-4045-8892-33dc6b01b3f9",
"timestamp" : "2024-04-23T13:44:32-04:00"
},
"title" : "Moderate Emetic Risk Intravenous Antineoplastic Agent",
"extension" : [ {
"valueString" : "American Society of Clinical Oncology Author",
"url" : "http://hl7.org/fhir/StructureDefinition/valueset-author"
}, {
"valueDate" : "2022-12-15",
"url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate"
}, {
"valueDate" : "2022-09-10",
"url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate"
}, {
"url" : "http://health-samurai.io/extensions/source",
"valueCode" : "db"
} ],
"status" : "active",
"id" : "dfb5e5a1-28c6-4ec4-b651-b70d6504323d",
"url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.5.243",
"identifier" : [ {
"system" : "urn:ietf:rfc:3986",
"value" : "urn:oid:2.16.840.1.113883.3.1444.5.243"
} ],
"version" : "20220910"
}